Multidisciplinary comprehensive treatments focused on intestinal function protection and recovery for malignant bowel obstruction

JIANG Bo

doi:10.7619/jcmp.201923001

Journal of Clinical Medicine in Practice > 2019 > 23(23): 1-4, 23. > DOI: 10.7619/jcmp.201923001

JIANG Bo. Multidisciplinary comprehensive treatments focused on intestinal function protection and recovery for malignant bowel obstruction[J]. Journal of Clinical Medicine in Practice, 2019, 23(23): 1-4, 23. DOI: 10.7619/jcmp.201923001

Citation:

PDF (1070 KB)

Multidisciplinary comprehensive treatments focused on intestinal function protection and recovery for malignant bowel obstruction

JIANG Bo

Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing, 100038

More Information

Received Date: October 11, 2019
Available Online: February 28, 2021
Published Date: December 14, 2019

Graphical Abstract

Abstract

Abstract

Malignant bowel obstruction is a common tumor complication secondary to digestive tract tumors and gynecological tumors. Individualized treatments were conducted to the patients with malignant bowel obstruction according to comprehensive multi-disciplinary opinions on tumor internal medicine and tumor surgery, intestinal function protection and recovery as core idea, nutritional therapy as the cornerstone, and personalized therapies such as intestinal stents, palliative surgery, low-dose chemotherapy, and symptomatic treatment. Taking intestinal function protection and recovery as core idea, the blind spots of knowledge at present through clinical practice was discovered from clinical classification to the decision-making of treatment in order to make a macroscopic, comprehensive and systematic understanding of malignant bowel obstruction, to ultimately improve the quality of life and prolong survival time of patients, and to provide decision-making reference for the multidisciplinary comprehensive treatments of intestinal function protection and recovery in malignant bowel obstruction patients.

FullText(HTML)

References (17)

References

[1]	Baines M, Oliver D J, Carter R L. Medical management of intestinal obstruction in patients with advanced malignant disease[J]. Lancet, 1985, 326(8462): 990-993. doi: 10.1016/S0140-6736(85)90534-3
[2]	Eljabu W, Finch G, Nottingham J, et al. Metastatic deposits of breast lobular carcinoma to small bowel and rectum[J]. Int J Breast Cancer, 2011, 2011: 1-4. http://www.ncbi.nlm.nih.gov/pubmed/22295221
[3]	Legendre H, Vanhuyse F, Caroli-Bosc F X, et al. Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction[J]. Eur J Surg Oncol EJSO, 2001, 27(4): 364-367. doi: 10.1053/ejso.2001.1120
[4]	Ripamonti C, Bruera E. Palliative management of malignant bowel obstruction[J]. Int J Gynecol Cancer, 2002, 12(2): 135-143. doi: 10.1046/j.1525-1438.2002.01103.x
[5]	Pedziwiatr M, Budzyński P, Stanek M, et al. Mechanical bowel obstruction: changes in aetiology over the past 145 years: A single centre retrospective cohort study[J]. Acta Chir Belg, 2015, 115(6): 397-403. doi: 10.1080/00015458.2015.11681140
[6]	Ni Q G, Ji H, Zhao Z H, et al. Endostar, a modified endostatin inhibits non small cell lung cancer cell in vitro invasion through osteopontin-related mechanism[J]. Eur J Pharmacol, 2009, 614(1/2/3): 1-6. http://www.ncbi.nlm.nih.gov/pubmed/19389394
[7]	Shi Y, Zhang X P, Qin H, et al. Naso-intestinal tube is more effective in treating postoperative ileus than Naso-gastric tube in elderly colorectal cancer patients[J]. Int J Colorectal Dis, 2017, 32(7): 1047-1050. doi: 10.1007/s00384-017-2760-5
[8]	Wang B, Wu G Y, Zhou Z G, et al. Glutamine and intestinal barrier function[J]. Amino Acids, 2015, 47(10): 2143-2154. doi: 10.1007/s00726-014-1773-4
[9]	Xia Z, Huang L, Yin P, et al. L-Arginine alleviates heat stress-induced intestinal epithelial barrier damage by promoting expression of tight junction proteins via the AMPK pathway[J]. Mol Biol Rep, 2019: Epub ahead of print.
[10]	Sowerbutts A M, Lal S, Sremanakova J, et al. Home parenteral nutrition for people with inoperable malignant bowel obstruction[J]. Cochrane Database Syst Rev, 2018, 8: CD012812.
[11]	Shariat-Madar B, Jayakrishnan T T, Gamblin T C, et al. Surgical management of bowel obstruction in patients with peritoneal carcinomatosis[J]. J Surg Oncol, 2014, 110(6): 666-669. doi: 10.1002/jso.23707
[12]	Alese O B, Kim S, Chen Z J, et al. Management patterns and predictors of mortality among US patients with cancer hospitalized for malignant bowel obstruction[J]. Cancer, 2015, 121(11): 1772-1778. doi: 10.1002/cncr.29297
[13]	Cousins S E, Tempest E, Feuer D J. Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer[J]. Cochrane Database Syst Rev, 2016(1): CD002764. http://www.ncbi.nlm.nih.gov/pubmed/11034757
[14]	Bateni S B, Gingrich A A, Stewart S L, et al. Hospital utilization and disposition among patients with malignant bowel obstruction: a population-based comparison of surgical to medical management[J]. BMC Cancer, 2018, 18(1): 1166-1173. doi: 10.1186/s12885-018-5108-9
[15]	Yang S, Li S, Yu H, et al. Metronomic chemotherapy with 5-fluorouracil and cisplatin for inoperable malignant bowel obstruction because of peritoneal dissemination from gastric cancer[J]. Curr Oncol, 2016, 23(3): e248-e252. doi: 10.3747/co.23.3010
[16]	Berger J, Lester P, Rodrigues L. Medical therapy of malignant bowel obstruction with octreotide, dexamethasone, and metoclopramide[J]. Am J Hosp Palliat Care, 2016, 33(4): 407-410. doi: 10.1177/1049909115569047
[17]	Soriano A, Davis M P. Malignant bowel obstruction: individualized treatment near the end of life[J]. Cleve Clin J Med, 2011, 78(3): 197-206. doi: 10.3949/ccjm.78a.10052

[1]	CHEN Chunmei, ZHANG Rong, CHU Jie, WANG Xuexing. Influencing factors of malnutrition in patients with colorectal cancer and value of Nomogram prediction model[J]. Journal of Clinical Medicine in Practice, 2024, 28(17): 20-26. DOI: 10.7619/jcmp.20241893
[2]	LUO Tian, XU Shu. Construction of a risk nomogram model of postoperative malnutrition in patients with oral cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(12): 31-35. DOI: 10.7619/jcmp.20240979
[3]	TANG Ling, WANG Wei, HAO Qiyan, WANG Jingjing. Influencing factors and construction of risk prediction model of malnutrition in patients with gastric cancer undergoing chemotherapy[J]. Journal of Clinical Medicine in Practice, 2024, 28(7): 79-84. DOI: 10.7619/jcmp.20231795
[4]	LI Yuanyuan, CHEN Jin, YU Xiujuan, XIONG Lingjie, LIU Dandan. Influencing factors of disability degree and correlations of disability with malnutrition and sarcopenia in elderly hospitalized patients with disability[J]. Journal of Clinical Medicine in Practice, 2024, 28(7): 67-71. DOI: 10.7619/jcmp.20233705
[5]	WEI Min, LIU Jun. Construction of a risk prediction model for malnutrition in maintenance hemodialysis patients[J]. Journal of Clinical Medicine in Practice, 2023, 27(10): 67-71,78. DOI: 10.7619/jcmp.20231186
[6]	ZHANG Shu, BAO Yun, CHEN Fang, WANG Yao, YANG Ming. Application of Global Leadership Initiative on Malnutrition standard in patients with maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2022, 26(5): 48-53. DOI: 10.7619/jcmp.20214021
[7]	YANG Yu, LIAN Yuying, ZHAO Yin. A consistency study of Global Leadership Initiative on Malnutrition standard, Patient-generated Subjective Global Assessment and serum albumin in diagnosis of malnutrition in cancer patients[J]. Journal of Clinical Medicine in Practice, 2022, 26(2): 82-87. DOI: 10.7619/jcmp.20212940
[8]	SUN Jinjie, SUN Yongqiang. Investigation on nutritional cognitive behavior of patients with inflammatory bowel disease and malnutrition analysis[J]. Journal of Clinical Medicine in Practice, 2020, 24(2): 83-86. DOI: 10.7619/jcmp.202002024
[9]	XU Chuanqin, HE Yuanqiang, CHEN Jianhui, ZHENG Yulong, LI Gang, WAN Yufeng. Effect of malnutrition on cognitive function of patients with chronic obstructive pulmonary disease in stable period[J]. Journal of Clinical Medicine in Practice, 2018, (7): 117-119,122. DOI: 10.7619/jcmp.201807033
[10]	MAO Chengye, WU Tianmu. Study on correlation of inflammatory responses and malnutrition in patients with chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2016, (17): 41-43. DOI: 10.7619/jcmp.201617013

Cited By

Cited by

Periodical cited type(8)

1.	杨群莉. 桂枝茯苓胶囊结合新生化颗粒在药物流产治疗中的应用. 内蒙古中医药. 2023(06): 18-20 .
2.	黄金秋. 补血益母丸联合短效避孕药对多次人工流产子宫内膜修复生育力保护及激素水平恢复的影响. 黑龙江医药. 2023(06): 1354-1356 .
3.	印岚. 米非司酮治疗人工流产术后持续阴道出血的临床效果. 妇儿健康导刊. 2023(05): 130-132+168 .
4.	张凤，沈晔，钱芳波，顾燕芳. 高危人工流产患者术中即时放置不同类型宫内节育器的有效性和安全性评价. 实用医院临床杂志. 2022(03): 65-68 .
5.	刘蕊. 新生化颗粒联合戊酸雌二醇、黄体酮对多次人工流产患者术后子宫恢复的影响. 医学理论与实践. 2022(16): 2792-2794 .
6.	韩菁，刘芳，黄恺. 不同人工流产术对妇女月经复潮时间、阴道出血时间及术后宫腔粘连发生率的影响. 中国基层医药. 2022(08): 1146-1150 .
7.	吕燕萍，梁秋峰. 全面放开三孩政策前后上海市嘉定区人工流产高危因素的变化. 实用临床医药杂志. 2022(23): 69-72 . 本站查看
8.	谈艳娟. 人流术后口服避孕药与放置宫内节育器临床疗效比较. 智慧健康. 2021(19): 79-81 .

Other cited types(0)

Get Citation

PDF

XML

Article views (200) PDF downloads (10) Cited by(8)

Turn off MathJax

Article Contents

Abstract

References

Multidisciplinary comprehensive treatments focused on intestinal function protection and recovery for malignant bowel obstruction